{"id":13713,"date":"2006-02-13T00:00:00","date_gmt":"2006-02-13T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/m004mtg257\/"},"modified":"2019-03-01T15:04:47","modified_gmt":"2019-03-01T15:04:47","slug":"m004mtg257","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004mtg257\/","title":{"rendered":"2nd Annual Summit on Post-Marketing Studies"},"content":{"rendered":"

Featured Conference<\/b> <\/p>\n

2nd Annual Summit on Post-Marketing Studies<\/b>
Design Post-Approval Studies for Improved Safety and Risk Assessment while Meeting Clinical, Marketing and Regulatory Objectives<\/i>
February 13 – 14, 2006 * London, UK <\/p>\n

Visit the conference website<\/a> for more information and to register.<\/b> <\/p>\n<\/p>\n

The Definitive Annual Forum for Providing Reliable Up-to-Date Information on Post-Marketing Studies<\/b><\/p>\n

The 2nd Annual Summit is the sequel to the very successful 2005 event that garnered over 120 attendees!\u00a0\u00a0This is the premier forum dedicated entirely to Post-Marketing Studies. Network at, and benefit from, the leading industry event!<\/p>\n

Post-Marketing studies in Europe are continuing to increase at a rapid pace and are being used widely to delineate additional information, including drug risks, benefits and optimal use.\u00a0 The EU clinical trials directive has had a dramatic impact on Post-Marketing Studies by establishing new definitions and bringing out more uniformity.<\/p>\n

The Summit\u2019s distinguished faculty is committed to providing the most current and applicable information on the design of Post-Marketing Studies including Phase IV studies, patient registries and epidemiologic studies to meet clinical, marketing and regulatory objectives.\u00a0 Attend this event and hear key insights on:<\/p>\n